1 year return (CAGR)
352.27%
I-Mab Exchange (NASDAQ, USD)
IMAB
-
+0.02 (+0.51%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
4.58%
5 year return (CAGR)
-37.58%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
458.76M
Price/Sales
-
Ent value
249.19M
Price/Book
1.77
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-39.72%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 3.96 |
| Daily high | 4.06 |
| Daily low | 3.90 |
| Daily Volume | 431K |
| 1y analyst estimate | 8.60 |
| Beta | 1.46 |
| EPS (TTM) | -0.09 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 1 Apr 2026 |
Downside potential
Loading...
Downside potential data
| IMAB | S&P500 | |
| Current price drop from All-time high | -95.29% | -1.23% |
| Highest price drop | -99.27% | -56.47% |
| Date of highest drop | 7 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -67.76% | -10.68% |
| Avg time to new high | 40 days | 12 days |
| Max time to new high | 1131 days | 1805 days |
News
No items found